MF-300
Asset
Inhibits 15-PGDH.
- Stage
- Phase 2
- Modality
- Small molecule
- Target
- HPGD
- 1
- Indication
- 0
- Trials
- 1
- Developer
Indications
1Sarcopenia
Phase 2, epirium.com, 10 Oct 2026
In the full profile
- Targets and what it contains1
- Owner and partners1
- Evidence for its targets2
- Competitors3
Every asset’s record: target, stage, trials and the evidence behind it.